Nifty
Sensex
:
:
10350.10
33527.39
51.35 (0.50%)
167.49 (0.50%)

Pharmaceuticals & Drugs

Rating :
35/99

BSE: 506943 | NSE: JBCHEPHARM

288.65
1.60 (0.56%)
21-Nov-2017 | 11:39AM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 287.65
  • 294.90
  • 286.00
  • 287.05
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  • 50354
  • 145.35
  • 367.95
  • 259.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,397.20
  • 15.98
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,432.68
  • 0.35%
  • 1.71

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 55.85%
  • 0%
  • 26.97%
  • FII
  • DII
  • Others
  • 0.03%
  • 7.66%
  • 9.49%

Chart

Price | P:E | P:BV | EV:EBITDA

Quarterly Results

Standalone Figures in Rs. Crores

Description
Jun 17
Jun 16
Var%
Mar 17
Mar 16
Var%
Dec 16
Dec 15
Var%
Sep 16
Sep 15
Var%
Net Sales
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBITDA
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PBT
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Net Sales
1,368.32
1,231.58
1,144.21
1,021.86
866.13
801.87
890.79
756.88
717.09
564.65
Net Sales Growth
11.10%
7.64%
11.97%
17.98%
8.01%
-9.98%
17.69%
5.55%
27.00%
 
Cost Of Goods Sold
552.00
491.41
341.40
413.95
371.52
320.07
277.04
178.72
187.62
141.11
Gross Profit
816.32
740.17
802.81
607.92
494.60
481.80
613.75
578.17
529.48
423.54
GP Margin
59.66%
60.10%
70.16%
59.49%
57.10%
60.08%
68.90%
76.39%
73.84%
75.01%
Total Expenditure
1,139.55
1,025.55
964.09
873.67
760.48
701.55
698.43
589.89
660.24
501.05
Power & Fuel Cost
54.89
55.28
53.02
46.61
39.75
29.89
23.34
18.04
15.97
16.59
% Of Sales
4.01%
4.49%
4.63%
4.56%
4.59%
3.73%
2.62%
2.38%
2.23%
2.94%
Employee Cost
206.54
175.31
159.56
143.67
130.05
112.66
124.93
91.71
87.82
85.83
% Of Sales
15.09%
14.23%
13.94%
14.06%
15.02%
14.05%
14.02%
12.12%
12.25%
15.20%
Manufacturing Exp.
131.45
119.35
223.53
102.44
61.75
52.97
60.85
102.74
108.00
77.49
% Of Sales
9.61%
9.69%
19.54%
10.02%
7.13%
6.61%
6.83%
13.57%
15.06%
13.72%
General & Admin Exp.
42.26
34.82
32.46
31.69
27.94
31.31
38.21
46.25
38.44
37.53
% Of Sales
3.09%
2.83%
2.84%
3.10%
3.23%
3.90%
4.29%
6.11%
5.36%
6.65%
Selling & Distn. Exp.
89.07
72.72
75.13
73.59
56.04
68.65
131.60
110.03
103.83
102.29
% Of Sales
6.51%
5.90%
6.57%
7.20%
6.47%
8.56%
14.77%
14.54%
14.48%
18.12%
Miscellaneous Exp.
63.34
76.65
79.01
61.72
73.44
86.00
42.47
42.41
118.56
102.29
% Of Sales
4.63%
6.22%
6.91%
6.04%
8.48%
10.72%
4.77%
5.60%
16.53%
7.12%
EBITDA
228.77
206.03
180.12
148.19
105.65
100.32
192.36
166.99
56.85
63.60
EBITDA Margin
16.72%
16.73%
15.74%
14.50%
12.20%
12.51%
21.59%
22.06%
7.93%
11.26%
Other Income
53.77
56.65
10.89
37.70
27.87
28.98
6.16
14.21
15.80
15.01
Interest
5.37
10.65
6.82
5.93
5.28
24.03
10.49
11.57
15.17
18.03
Depreciation
47.22
41.22
38.64
28.02
24.66
22.42
22.79
21.57
20.43
16.90
PBT
229.94
210.82
145.55
151.94
103.57
82.85
165.24
148.07
37.06
43.69
Tax
45.55
49.58
45.14
25.95
24.13
165.53
25.92
29.32
11.35
-1.63
Tax Rate
19.81%
23.52%
31.01%
29.68%
23.30%
19.63%
15.69%
19.80%
30.63%
-3.73%
PAT
184.06
161.14
100.41
61.50
79.44
677.91
139.32
118.75
25.71
45.32
PAT before Minority Interest
184.40
161.24
100.41
61.50
79.44
677.91
139.32
118.75
25.71
45.32
Minority Interest
-0.34
-0.10
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
13.45%
13.08%
8.78%
6.02%
9.17%
84.54%
15.64%
15.69%
3.59%
8.03%
PAT Growth
14.22%
60.48%
63.27%
-22.58%
-88.28%
386.58%
17.32%
361.88%
-43.27%
 
Unadjusted EPS
21.42
19.14
11.84
7.26
9.38
80.11
16.50
14.08
3.05
5.37

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Shareholder's Funds
1,363.67
1,183.84
994.87
1,042.81
1,020.27
969.95
691.54
568.12
468.89
453.02
Share Capital
16.96
16.96
16.96
16.95
16.94
16.94
16.90
16.87
16.87
16.87
Total Reserves
1,346.70
1,166.87
977.91
1,025.82
1,003.22
952.83
674.31
550.81
451.58
435.71
Non-Current Liabilities
26.98
31.02
32.62
31.93
40.45
39.52
36.50
152.63
191.61
211.83
Secured Loans
0.00
0.00
0.00
0.09
0.22
0.40
0.54
98.49
134.30
154.50
Unsecured Loans
0.00
0.00
0.40
0.40
7.03
12.14
11.99
38.29
44.47
41.86
Long Term Provisions
12.56
10.43
12.03
12.19
8.23
8.27
7.71
0.00
0.00
0.00
Current Liabilities
693.46
797.22
459.75
276.27
239.48
188.32
271.33
116.55
85.81
76.45
Trade Payables
98.98
90.85
77.51
60.75
60.51
37.09
50.21
43.28
34.55
43.73
Other Current Liabilities
122.15
138.73
103.74
98.06
101.15
78.75
61.22
39.53
30.10
17.68
Short Term Borrowings
48.86
193.02
126.88
81.71
37.28
55.23
133.36
0.00
0.00
0.00
Short Term Provisions
423.47
374.61
151.62
35.76
40.54
17.26
26.54
33.74
21.16
15.05
Total Liabilities
2,086.29
2,013.75
1,487.24
1,351.01
1,300.20
1,197.79
999.37
837.30
746.31
741.30
Net Block
679.44
440.22
328.56
310.55
334.41
276.31
258.39
246.78
246.71
259.29
Gross Block
1,038.55
753.75
601.67
540.54
537.46
456.51
420.25
386.67
366.57
359.92
Accumulated Depreciation
359.10
313.53
273.11
229.99
203.06
180.19
161.85
139.89
119.86
100.63
Non Current Assets
879.15
831.58
586.31
370.37
356.49
331.58
278.78
271.13
260.89
269.10
Capital Work in Progress
3.76
134.89
55.17
46.36
4.81
39.00
3.75
0.08
6.69
2.29
Non Current Investment
185.84
231.42
184.83
2.75
2.99
3.00
3.94
24.27
7.49
7.52
Long Term Loans & Adv.
9.22
22.63
17.74
10.71
14.28
13.27
12.70
0.00
0.00
0.00
Other Non Current Assets
0.88
2.43
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
1,207.14
1,182.16
900.94
980.65
943.71
866.22
720.60
566.17
485.42
472.21
Current Investments
224.96
247.28
366.78
497.26
394.68
298.92
81.05
0.00
0.00
0.00
Inventories
200.17
187.98
150.27
134.40
104.53
101.03
111.67
83.81
80.77
74.69
Sundry Debtors
265.97
272.64
262.35
235.51
191.27
136.05
345.58
344.82
302.80
322.42
Cash & Bank
13.39
12.90
25.19
11.81
156.23
219.53
126.89
77.86
43.85
14.96
Other Current Assets
502.66
2.51
0.38
0.20
96.99
110.69
55.41
59.68
58.00
60.13
Short Term Loans & Adv.
502.60
458.83
95.97
101.48
96.84
110.29
54.66
59.58
57.87
60.13
Net Current Assets
513.68
384.94
441.19
704.37
704.23
677.90
449.27
449.62
399.61
395.75
Total Assets
2,086.29
2,013.74
1,487.25
1,351.02
1,300.20
1,197.80
999.38
837.30
746.31
741.31

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Cash From Operating Activity
200.20
140.41
126.66
-13.98
84.20
879.69
133.92
121.97
91.11
28.31
PBT
229.94
212.23
145.55
87.44
103.57
843.44
165.34
148.07
37.06
43.69
Adjustment
15.32
-1.40
38.51
20.75
-4.40
33.13
16.60
25.01
63.44
35.22
Changes in Working Capital
2.77
-16.96
-19.52
-93.71
9.47
167.35
-15.87
-22.77
1.75
-42.73
Cash after chg. in Working capital
248.04
193.88
164.53
14.49
108.65
1,043.91
166.07
150.31
102.25
36.18
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-47.84
-53.47
-37.87
-28.47
-24.45
-164.22
-32.15
-28.33
-11.14
-7.87
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-43.55
-27.62
-111.89
-142.50
-116.05
-260.92
-89.46
-29.46
-14.31
-28.06
Net Fixed Assets
-152.86
-187.76
-69.64
-55.43
-41.77
-69.55
-32.72
-10.92
-13.11
-28.00
Net Investments
67.89
-14.16
-61.38
-102.46
-95.95
-214.42
-60.83
-16.87
-2.68
-9.37
Others
41.42
174.30
19.13
15.39
21.67
23.05
4.09
-1.67
1.48
9.31
Cash from Financing Activity
-182.90
-99.62
-1.39
12.04
-31.45
-526.12
4.56
-58.49
-47.91
-5.67
Net Cash Inflow / Outflow
-26.26
13.17
13.38
-144.43
-63.30
92.65
49.02
34.02
28.88
-5.42
Opening Cash & Equivalents
9.42
-5.46
11.81
156.23
219.53
126.89
77.86
43.85
14.96
20.39
Closing Cash & Equivalent
-16.83
9.42
25.19
11.81
156.23
219.53
126.89
77.86
43.85
14.96

Financial Ratios

Consolidated /

Standalone
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Book Value (Rs.)
160.77
139.57
117.31
123.07
119.21
113.34
80.86
66.82
55.35
53.53
ROA
8.99%
9.21%
7.08%
4.64%
6.36%
61.71%
15.17%
15.00%
3.46%
6.24%
ROE
14.48%
14.80%
9.86%
5.99%
8.07%
82.49%
22.35%
23.05%
5.60%
10.43%
ROCE
16.87%
17.72%
13.49%
8.50%
10.41%
92.09%
22.63%
23.71%
8.07%
9.95%
Fixed Asset Turnover
1.53
1.82
2.03
1.92
1.76
1.85
2.22
2.03
2.00
1.74
Receivable days
71.84
79.28
78.41
75.30
68.16
108.62
140.48
154.96
157.34
198.66
Inventory Days
51.77
50.12
44.83
42.16
42.80
47.97
39.77
39.38
39.12
49.46
Payable days
32.86
32.45
27.82
26.91
26.15
26.89
25.89
27.07
26.89
43.96
Cash Conversion Cycle
90.75
96.95
95.43
90.54
84.81
129.69
154.35
167.27
169.57
204.15
Total Debt/Equity
0.04
0.16
0.13
0.09
0.05
0.07
0.25
0.24
0.38
0.44
Interest Cover
43.81
20.80
22.33
15.74
20.61
36.10
16.75
13.80
3.44
3.42

News Update:


  • JB Chem & Pharma - Quarterly Results
    10th Nov 2017, 12:00 AM

    Read More
  • ICICI Lombard buys 20 lakh shares of JB Chemicals
    2nd Nov 2017, 10:39 AM

    Ashish Dhawan has offloaded 19.52 lakh shars of the company at Rs 288.12 on the NSE

    Read More
  • Kotak Mahindra AMC sells 6 lakh shares of JB Chemicals & Pharmaceuticals
    26th Oct 2017, 09:11 AM

    It has sold 6,00,659 shares of the company at Rs 280 per share on the NSE on October 25, 2017

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.